Phase 3, randomized, double-blind, placebo-controlled study (P303) assessing efficacy and safety of extended-release viloxazine in children with ADHD

Authors
Category Primary study
ConferenceCNS Spectrums
Year 2020
This article has no abstract
Epistemonikos ID: d756160fec9cc59dcd8f20752dead3e92febb240
First added on: Apr 29, 2026